New Director Appointed at Vor Biopharma (VOR), Reports No Holdings
Vor Biopharma Inc.
Subscribe to track VOR
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
New Director Appointed at Vor Biopharma (VOR)
Company: Vor Biopharma Inc. (VOR) Form: 3 | Filed: 2025-12-19 Significance: Low
Insider: Joustra Wouter Title: null | Relationship: Director
Transaction: • Type: Initial Ownership Statement • Shares Held: 0 • Value: $0
Key Insight: This is a routine Form 3 filing for a newly appointed director, Joustra Wouter, who currently holds no shares in the company. This is an administrative filing with no immediate market impact.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Vor Biopharma Inc. (VOR)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A new director, Joustra Wouter, has filed an initial statement of beneficial ownership (Form 3), reporting that they do not currently own any shares of Vor Biopharma Inc.
- Market Impact: Neutral. This is a standard administrative filing required for new insiders and does not indicate any trading activity.
Company Information
| Field | Value |
|---|---|
| Company | Vor Biopharma Inc. |
| Ticker Symbol | VOR |
| CIK | 0001817229 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Joustra Wouter |
| CIK | 0001897813 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
This filing indicates the insider holds no securities. There are no transactions to report.
| Field | Value |
|---|---|
| Form Type | 3 |
| Event Date | 2025-12-18 |
| Transaction Code | null |
| Security Type | null |
| Shares Involved | 0 |
| Price Per Share | null |
| Total Value | $0 |
| Shares Owned After | 0 |
| Ownership Type | null |
Financial Impact Assessment
Transaction Materiality
As no transaction occurred and no shares are held, there is no financial impact or materiality to assess. The filing simply establishes a baseline of zero ownership for the new director.
Impact Evaluation
- Market Cap Context: Vor Biopharma is a nano-cap company with a market capitalization of approximately $70 million. While any future insider transactions would be noteworthy given the company's size, this initial filing has no impact.
- Ownership Concentration: The insider currently has zero ownership.
- Transaction Significance: The significance is low, as this is a procedural filing confirming the appointment of a new director with no initial stake.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: A Form 3 reporting zero shares is a non-event for the market. It is purely informational and does not signal any insider sentiment.
Volume & Sentiment
- Expected Volume Impact: None. This type of filing does not typically influence trading volume.
- Sentiment Indicator: Neutral. The filing provides no bullish or bearish signals.
Additional Context
Transaction Notes
- This Form 3 is an initial statement of beneficial ownership, required within 10 days of an individual becoming a director, officer, or 10% owner of a public company. It establishes the insider's starting ownership position, which in this case is zero.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.